меланома и диета

The private residence costs{stands} research ICON-3 in which 2039 patients Ic-IV with stages of a cancer яичников have taken part. In control group patients received карбоплатин in doze AUC> 5 or combination САР (500/50/50 mg / m2), in compared group - a combination цисплатина and паклитаксела (75/175 mg / m2). Treatment was carried out{was spent} each 3 weeks in volume of 6 rates. The preliminary data testify that time before progressing and general life expectancy was identical irrespective of used chemotherapy. Sick (57 %) in group карбоплатина and CAP received the majority таксаны as chemotherapy of the second line that explains rather good remote results. Подробнее...

Researchers from Center MD Anderson in 1998 publish 5-years results of treatment of patients инвазивным cancer I-II of a stage with one-stage reconstruction, also having divided{shared} patients on two groups as executed мастэктомии with one-stage reconstruction - with preservation of a leather{skin} (104 patients) and without (27 patients) [36]. The percent{interest} of local relapses has made accordingly - 6,7 % and 7,4 %, system progressing of illness of 12,5 % against 25,9 % in group standard мастэктомии, parameters безрецидивной and the general{common} survival rate in the first group have made 88,5 % and 80,8 %, and in the second 74,1 % and 55,6 %. Certainly, in the given situation it is possible to think of absence of impartiality of the surgeons choosing methods for treatment of those or other patients when the patient with more worse forecast carried out standard operative interventions. Подробнее...